QMS Medical Allied Services Limited (QMSMEDI)
Shareholders meeting
Summary of proceedings of 09th AGM held on Sep 30, 2026 via VC
- Standalone FY26 revenue ₹152.30 Cr (+5.1%), EBITDA ₹20.50 Cr, PAT ₹6.69 Cr
- Consolidated FY26 revenue ₹172.88 Cr (+10.8%), EBITDA ₹25.88 Cr, PAT ₹11.92 Cr
- Final dividend recommended: 5% (₹0.50/share) subject to approval
- Strategic moves: NSE Mainboard migration, Saarathi acquisition, proposed Composite Scheme
- Signed 5-year exclusive distribution deal with HEINE Optotechnik from Jan 2027
- Expansion plans include BeamOptics investment and Q Devices brand growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 QMSMEDI — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add QMSMEDI to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on QMS Medical Allied Services Limited
Important.
The summary above is generated automatically from QMS Medical Allied Services Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.